Lv21
112 积分 2024-10-08 加入
TAK1 confers antibacterial protection through mediating the activation of MAPK and NF-κB pathways in shrimp
6小时前
已完结
Targeting MAPK signaling: A promising approach for treating inflammatory lung disease
3天前
已完结
Signaling Pathways in Inflammation and Anti-inflammatory Therapies
8天前
已完结
Combating bacterial infections with host defense peptides: Shifting focus from bacteria to host immunity
26天前
已完结
TLR/MyD88/NF-κB信号通路参与不同疾病作用机制研究进展
30天前
已完结
Tuberculosis drug discovery: Progression and future interventions in the wake of emerging resistance
30天前
已完结
Repurposing of FDA approved drugs against uropathogenic Escherichia coli: In silico, in vitro, and in vivo analysis
1个月前
已完结
An analysis of FDA-approved drugs for infectious disease: antibacterial agents
1个月前
已完结
Sulbactam‐durlobactam: A novel β‐lactam‐β‐lactamase inhibitor combination targeting carbapenem‐resistant Acinetobacter baumannii infections
1个月前
已完结
Optimizing antimicrobial use: challenges, advances and opportunities
1个月前
已完结
皖公网安备34019202002308
